HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Galantamin

HCID 3449
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
357-70-0
Standard SMILES
COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2
InChIKey
ASUTZQLVASHGKV-UHFFFAOYSA-N
Molecular formula
C17H21NO3
Average molar mass
287.35 g/mol
Monoisotopic mass
287.15214353

Overview

LSM-1597 is an alkaloid.

Names & identifiers

Preferred name
Galantamin
IUPAC
9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol
English name
Galanthamine
Molecular formula
C17H21NO3
Molecular weight
287.35

Names & synonyms

Galantamin9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol9-methoxy-4-methyl-11-oxa-4-azatetracyclo(8.6.1.01,12.06,17)heptadeca-6(17),7,9,15-tetraen-14-olRefChem:1085649EpigalanthaminMLS000766281NSC1000586H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-epigalanthamineGalanthamine #Galanthamine baseGalanthamine,(3.alpha.-
Show more names
GALANTAMINEGalantamina(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-olRazadyneGalanthamine-d3 HCl(4aS,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6β-olJilkonReMinylR-113675
Oprea1_097473Oprea1_098077SCHEMBL220427CERAPP_13557CHEMBL1623394SCHEMBL31401865CHEBI:91735DTXSID70859345

Database identifiers

CAS
357-70-0
PubChem CID
3449
DTXSID
DTXSID70859345
ChEMBL
CHEMBL1623394
ChEBI
CHEBI:91735
Nikkaji
J1.441.242E

Properties

Computed structural propertiesFilling in

XLogP
1.8
Topological polar surface area
41.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
1
Heavy atoms
21
Formal charge
0
Complexity
440

Experimental & physicochemical properties

DrugsPharmaceuticals

Physicochemical properties

Melting point
119 · 119-1210C
alpha
20 · D20 -118.8° (c = 1.378 in ethanol)
Boiling point
429.65 °C · 429.65°C (rough estimate)
Density
1.0662 · 1.0662 (rough estimate)
refractive index
1.5022 · 1.5022 (estimate)
storage temp.
Sealed in dry,Room Temperature
solubility
14.37 mg/mL · ≥14.37 mg/mL in DMSO; ≥14.43 mg/mL in H2O with gentle warming; ≥45 mg/mL in EtOH with gentle warming
form
Powder
pka
8.32 · pKa 8.32 (Uncertain)
color
White to off-white
InChI
InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Toxicity
LD50 intraperitoneal in mouse: 10mg/kg
Signal word
Danger
Symbol(GHS)
GHS09,GHS06
Hazard statements
H319-H373-H410-H317-H315-H301+H331
Precautionary statements
P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P260-P314-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P-P273-P391-P501
Hazardous Substances Data
357-70-0(Hazardous Substances Data)

Chemistry & industry

Applications · 8 items

UsesIt is used for neurological diseases and trauma-induced movement disorders, multiple neuritis, ramitis and so on.

DescriptionGalantamine is an Amaryllidaceae alkaloid which is first obtained from the plant of snowdrop (Galanthus nivalis), and nowadays, it’s extracted from the plants of Narcissus and Galanthus species or obtained from chemosynthesis. In many areas in Europe such as Bulgaria, eastern Turkey, and the Caucasus, the plants of Galanthus are native species. But its earliest pharmaceutical applications are seldom known. Plaitakis and Duvoisin hypothesized that “moly” in ancient Homer’s epic might be snowdrops. In Homer’s epic Odyssey, “moly” was used as an antidote by Odysseus against Circe’s poisonous drugs. To be used as an antidote may be the plants of Galanthus’ oldest medicinal records. But there is not much evidence for that. There is little evidence of the traditional application of the plants of Galanthus, and it is certain that until the Second World War, the plants of Galanthus and other genera of Amaryllidaceae were not frequently used in European drugsItalian scholar Iannello studied Pancratium illyricum L., an Amaryllidaceae species endemic to Sardinia, and isolated a new galantamine-type alkaloid in its leaves. This new galantamine-type compound exhibited a pronounced invitro AChE inhibitory activity (IC50 = 3.5±1.1 μM) in comparison with the reference standard galantamine hydrobromide (IC50=1.5±0.2μM)

OccurrenceGalanthamine is a bulb plant found throughout the world.

HistoryIn the early 1950s, Soviet Union’s scientists started modern medicine research of galantamine. In 1951, the Soviet Union’s pharmacologist Mashkovsky and Kruglikova-Lvova firstly proved its AChE-inhibiting properties, which was published in the paper. In 1957, the Bulgarian pharmacologist Paskov etal. found that the plants of Galanthus were the richest sources of galantamine, which opened a way for its commercial development by the company Sopharma in Bulgaria. Galantamine hydrobromide was launched into market under the trade name Nivalin. Initially, Nivalin was used in anesthesia to antagonize the effects of non-depolarizing muscle relaxants, and since then, it was rapidly introduced in other areas of medicineGalantamine hydrobromide was launched into market for the indication of mild to moderate Alzheimer’s disease firstly in 1995, developed by Sanochemia Pharmaceuticals. In the United States, galantamine hydrobromide was developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and was listed under the trade name Razadyne in 2001. So far, galantamine hydrobromide has been marketed in more than 20 countries and regions, such as the United States, Europe, and Japan.

Related reactions

3 records
New reaction record
HRID 22461 reaction equation
HRID 22461As reactantuspto-grants-1995_06
HRID 850695 reaction equation
HRID 850695As reactantuspto-grants-2000_01
HRID 850696 reaction equation
HRID 850696As reactantuspto-grants-2000_01

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
InChIKey
ASUTZQLVASHGKV-JDFRZJQESA-N
SMILES
N1(C)CC2=CC=C(OC)C3O[C@]4([H])[C@@](C=C[C@H](O)C4)(C2=3)CC1
CAS DataBase Reference
357 · 357-70-0(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
0 D3Q044KCA · 0D3Q044KCA
NCI Drug Dictionary
Razadyne
ATC code
6 DA04 · N06DA04
NIST Chemistry Reference
Galantamin(357-70-0)
Protein binding
18 % · 18%
Excreted unchanged in urine
18 · 18-22%
Volume of distribution
175 Litres · 175 Litres
Biological half-life
7 · 7-8 (XL: 8-10) / Increased
Symbol(GHS)
9 · GHS09,GHS06
Signal word
Danger
Hazard statements
319 · H319-H373-H410-H317-H315-H301+H331
Precautionary statements
261 · P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P260-P314-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P-P273-P391-P501
Hazardous Substances Data
357 · 357-70-0(Hazardous Substances Data)
Toxicity
50 intraperitoneal · LD50 intraperitoneal in mouse: 10mg/kg

Usessynthetic fluoroquinolone antibiotic agent

UsesGalantamine is approved for the treatment of mild-to-moderate AD.It is a reversible specific inhibitor of AChE,and in addition it modulates central nicotinic receptors toincrease cholinergic neurotransmission.

UsesA selective acetylcholinesterase inhibitor. Useful for the treatment of Alzheimer's disease.

General DescriptionGalantamine, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro-[3a,3,2,ef][2]-benzazepin-6-ol (Nivalin, Reminyl), is an alkaloid extractedfrom the tuberous plant Leucojum aestivum (L.) belongingto the Amaryllidaceae family and from the bulbs of thedaffodil, Narcissus pseudonarcissus. It is a reversiblecholinesterase inhibitor that appears to have no effect on butyrylcholinesterase.In addition, it acts at allosteric nicotinicsites, further enhancing its cholinergic activity. Galantamineundergoes slow and minor biotransformation with approximately5% to 6% undergoing demethylation. It is primarilyexcreted in the urine.

Upstream & downstream products

Upstream raw materials

AmmoniaSodium carbonateSulfuric acidHydrogen bromide

Downstream products

O-Desmethylgalanthamine(3α)-3-Deoxy-3-chlorogalanthaMine

Additional notes

DefinitionChEBI: A natural product found in Crinum asiaticum var. sinicum.